Investigating an in silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression
- 17 September 2020
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 21 (1) , 85-93
Abstract
In clinical practice, an antidepressant prescription is a trial and error approach, which is time consuming and discomforting for patients. This study investigated an in silico approach for ranking antidepressants based on their hypothetical likelihood of efficacy. We predicted the transcriptomic profile of citalopram remitters by performing an in silico transcriptomic-wide association study on STAR*D GWAS data (N = 1163). The transcriptional profile of remitters was compared with 21 antidepressant-induced gene expression profiles in five human cell lines available in the connectivity-map database. Spearman correlation, Pearson correlation, and the Kolmogorov–Smirnov test were used to determine the similarity between antidepressant-induced profiles and remitter profiles, subsequently calculating the average rank of antidepressants across the three methods and a p value for each rank by using a permutation procedure. The drugs with the top ranks were those having a high positive correlation with the expression profiles of remitters and that may have higher chances of efficacy in the tested patients. In MCF7 (breast cancer cell line), escitalopram had the highest average rank, with an average rank higher than expected by chance (p = 0.0014). In A375 (human melanoma) and PC3 (prostate cancer) cell lines, escitalopram and citalopram emerged as the second-highest ranked antidepressants, respectively (p = 0.0310 and 0.0276, respectively). In HA1E (kidney) and HT29 (colon cancer) cell types, citalopram and escitalopram did not fall among top antidepressants. The correlation between citalopram remitters’ and (es)citalopram-induced expression profiles in three cell lines suggests that our approach may be useful and with future improvements, it can be applicable at the individual level to tailor treatment prescription.Keywords
All Related Versions
Funding Information
- DH | National Institute for Health Research
This publication has 32 references indexed in Scilit:
- Contribution of Common Genetic Variants to Antidepressant ResponseBiological Psychiatry, 2013
- Stem Cell Fate Determination during Development and Regeneration of Ectodermal OrgansFrontiers in Physiology, 2012
- Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel DiseaseScience Translational Medicine, 2011
- Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression DataScience Translational Medicine, 2011
- Biomarkers to Predict Antidepressant ResponseCurrent Psychiatry Reports, 2010
- A Bayesian Framework to Account for Complex Non-Genetic Factors in Gene Expression Levels Greatly Increases Power in eQTL StudiesPLOS Computational Biology, 2010
- A Genomewide Association Study of Citalopram Response in Major Depressive DisorderBiological Psychiatry, 2010
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionBiological Psychiatry, 2003